Dual Cytotoxic Responses Induced by Treatment of A549 Human Lung Cancer Cells with Sweet Bee Venom in a Dose-Dependent Manner
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Sweet bee venom (sBV) is purified from Apis mellifera, containing a high level of melittin—its main component. It has been used as a therapeutic agent for pain relief and anti-inflammation, as well as for treating neuronal abnormalities. Recently, there have been studies on the therapeutic application of sBV for anticancer treatment. In the present study, we investigated the pharmacological effect of sBV treatment in A549 human lung cancer cells. Methods: We used microscopic analysis to observe the morphological changes in A549 cells after sBV treatment. The MTT assay was used to examine the cytotoxic effect after dose-dependent sBV treatment. Molecular changes in sBV were evaluated by the expression of apoptosis marker proteins using western blot analysis. Results: Microscopic analysis suggested that the growth inhibitory effect occurred in a dose-dependent manner; however, cell lysis occurred at a concentration over 20 μg/mL of sBV. The MTT assay indicated that sBV treatment exhibited a growth inhibitory effect at a concentration over 5 μg/mL. On fluorescence activated cell sorting analysis, G0 dead cells were observed after G1 arrest at treatment concentrations up to 10 μg/mL. However, rapid cell rupture was observed at a concentration of 20 μg/mL. Western blot analysis demonstrated that sBV treatment modulated the expression of multiple cell death-related proteins, including cleaved-PARP, cleaved-caspase 9, p53, Bcl2, and Bax. Conclusion: sBV induced cell death in A549 human lung cancer cells at a pharmacological concentration, albeit causing hemolytic cell death at a high concentration.
Abstract
Objectives: Sweet bee venom (sBV) is purified from Apis mellifera, containing a high level of melittin—its main component. It has been used as a therapeutic agent for pain relief and anti-inflammation, as well as for treating neuronal abnormalities. Recently, there have been studies on the therapeutic application of sBV for anticancer treatment. In the present study, we investigated the pharmacological effect of sBV treatment in A549 human lung cancer cells. Methods: We used microscopic analysis to observe the morphological changes in A549 cells after sBV treatment. The MTT assay was used to examine the cytotoxic effect after dose-dependent sBV treatment. Molecular changes in sBV were evaluated by the expression of apoptosis marker proteins using western blot analysis. Results: Microscopic analysis suggested that the growth inhibitory effect occurred in a dose-dependent manner; however, cell lysis occurred at a concentration over 20 μg/mL of sBV. The MTT assay indicated that sBV treatment exhibited a growth inhibitory effect at a concentration over 5 μg/mL. On fluorescence activated cell sorting analysis, G0 dead cells were observed after G1 arrest at treatment concentrations up to 10 μg/mL. However, rapid cell rupture was observed at a concentration of 20 μg/mL. Western blot analysis demonstrated that sBV treatment modulated the expression of multiple cell death-related proteins, including cleaved-PARP, cleaved-caspase 9, p53, Bcl2, and Bax. Conclusion: sBV induced cell death in A549 human lung cancer cells at a pharmacological concentration, albeit causing hemolytic cell death at a high concentration.
참고문헌 (24)
- Abdela N, "Bee venom and its therapeutic values : a review", Adv Life Sci Technol, 44, pp.18~22 (2016)
- Ali M, "Studies on bee venom and its medical uses", Int J Adv Res Technol, 1(2), pp.69~83 (2012)
- Golden DB, "Insect sting allergy and venom immunotherapy: a model and a mystery", J Allergy Clin Immunol, 115(3), pp.439~447 (2005)
- Lieberman P, "Anaphylaxis and cardiovascular disease:therapeutic dilemmas", Clin Exp Allergy, 45(8), pp.1288~1295 (2015)
- Hossen MS, "Impact of bee venom enzymes on diseases and immune responses", Molecules, 22(1), pp.25~ (2016)
- 조나영, "Systemic Immediate Hypersensitive Reactions after Treatment with Sweet Bee Venom: A Case Report", Journal of Pharmacopuncture, 18(4), pp.59~62 (2015), 대한약침학회[DOI]
- Park JW, "Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy : a case series", Integr Cancer Ther, 11(2), pp.166~171 (2012)
- Jeong YJ, "Melittin has an inhibitory effect on TNF-α-induced migration of human aortic smooth muscle cells by blocking the MMP-9expression", Food Chem Toxicol, 50(11), pp.3996~4002 (2012)
- Tusiimire J, "Effect of bee venom and its fractions on the release of pro-inflammatory cytokines in PMA-differentiated U937cells co-stimulated with LPS", Vaccines (Basel), 4(2), pp.11~ (2016)
- Lyu C, "Anti-tumor effects of melittin and its potential applications in clinic", Curr Protein Pept Sci, 20(3), pp.240~250 (2019)
- Rady I, "Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy", Cancer Lett, 402, pp.16~31 (2017)
- Jo M, "Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2", STAT3 pathway, 2012, pp.258(1), 72~81
- Liu CC, "Application of bee venom and its main constituent melittin for cancer treatment", Cancer Chemother Pharmacol, 78(6), pp.1113~1130 (2016)
- Zhou C, "TERT promoter regulating melittin expression induces apoptosis and G0", G1 cell cycle arrest in esophageal carcinoma cells, 2021, pp.21(1), 16~
- Mansour GH, "Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells", Bioorg Chem, 116, pp.105329~ (2021)
- Ryu JM, "Sweet bee venom triggers multiple cell death pathways or spurs acute cell rupture according to its concentration in THP-1 monocytic leukemia cells", Genes (Basel), 13(2), pp.223~ (2022)
- Kim H, "Potential therapeutic applications of bee venom on skin disease and its mechanisms : a literature review", Toxins (Basel), 11(7), pp.374~ (2019)
- Yavari M, "Melittin and breast cancer : a brief review of the evidence", J Nur Patient Saf, 1, pp.1~7 (2020)
- Wang A, "Melittin-based nano-delivery systems for cancer therapy", Biomolecules, 12(1), pp.118~ (2022)
- Choi KE, "Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells", Toxins (Basel), 6(8), pp.2210~2228 (2014)
- Wen T, "Perspectives and controversies regarding the use of natural products for the treatment of lung cancer", Cancer Med, 10(7), pp.2396~2422 (2021)
- Lin TY, "Clinical applications of bee venom acupoint injection", Toxins (Basel), 12(10), pp.618~ (2020)
- Duffy C, "Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer", NPJ Precis Oncol, 4, pp.24~ (2020)
- Oršolić N, "Bee venom in cancer therapy", Cancer Metastasis Rev, 31(1-2), pp.173~194 (2012)